drugset

drugset / Trial / NCT03098615

Study Evaluating the Effect of Jublia on Dermatophytomas

NCT03098615 ↗

Phase 4 Completed 19 enrolled University of Alabama at Birmingham

NaSingle-groupOpen-labelTreatment

Summary

This study will examine how Jublia affects dermatophytomas, which are difficult to treat with other therapeutic options.

Timeline

Start: 2015-09
Primary completion: 2017-05
Completion: 2018-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Efinaconazole	Small molecule	10 %	Topical

Indications